Production of antibodies in transgenic plants

Nature
A HiattK Bowdish

Abstract

Complementary DNAs derived from a mouse hybridoma messenger RNA were used to transform tobacco leaf segments followed by regeneration of mature plants. Plants expressing single gamma or kappa immunoglobulin chains were crossed to yield progeny in which both chains were expressed simultaneously. A functional antibody accumulated to 1.3% of total leaf protein in plants expressing full-length cDNAs containing leader sequences. Specific binding of the antigen recognized by these antibodies was similar to the hybridoma-derived antibody. Transformants having gamma- or kappa-chain cDNAs without leader sequences gave poor expression of the proteins. The increased abundance of both gamma- and kappa-chains in transformants expressing assembled gamma-kappa complexes was not reflected in increased mRNA levels. The results demonstrate that production of immunoglobulins and assembly of functional antibodies occurs very efficiently in tobacco. Assembly of subunits by sexual cross might be a generally applicable method for expression of heterologous multimers in plants.

References

Nov 1, 1979·The Journal of Cell Biology·A Tartakoff, P Vassalli
Apr 1, 1988·Molecular and Cellular Biology·K T RiabowolJ R Feramisco
Aug 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J S HustonR Crea
Nov 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·A H HorwitzR R Robinson
Jun 1, 1988·Molecular and Cellular Biology·J R Carlson
Oct 21, 1988·Science·R E BirdM Whitlow
Dec 19, 1986·Science·A TramontanoR A Lerner

❮ Previous
Next ❯

Citations

Jun 5, 1997·Biotechnology and Bioengineering·R Wongsamuth, P M Doran
Jul 22, 2008·Biotechnology and Bioengineering·A R KusnadiJ A Howard
Apr 26, 2001·Biotechnology and Bioengineering·J M Sharp, P M Doran
May 1, 1992·Plant Molecular Biology·N T Keen
Oct 1, 1992·Plant Molecular Biology·S Y Bednarek, N V Raikhel
Nov 1, 1994·Plant Molecular Biology·U Conrad, U Fiedler
Jul 1, 1995·World Journal of Microbiology & Biotechnology·G Kahl, P Winter
Jan 1, 1990·Archives of Virology·F GadaniJ H Hill
Jul 1, 1995·Transgenic Research·C EadyK Lindsey
Mar 5, 2005·Analytical and Bioanalytical Chemistry·Rene KizekFrantisek Jelen
Sep 2, 2005·Plant Cell Reports·Tara L WalkerChris Collet
Oct 6, 2005·Transgenic Research·Anna K HullVadim Mett
Oct 3, 2008·Transgenic Research·Ganesan SunilkumarKeerti S Rathore
Oct 29, 2009·Transgenic Research·Yi-Hui Audrey Teh, Tony A Kavanagh
Nov 30, 2000·Current Infectious Disease Reports·J Yu, W H Langridge
Oct 1, 1992·Journal of Biotechnology·A Kh Lipsky
Jan 1, 1994·Parasitology Today·A NiebelM Van Montagu
Jan 1, 1990·Biotechnology Advances·B R Glick
Jan 1, 1995·Biotechnology Advances·K P Pauls
Jan 1, 1996·Biotechnology Advances·M D Smith
Apr 1, 1991·Current Opinion in Biotechnology·A Plückthun
Mar 9, 2004·Current Opinion in Plant Biology·Scott E Franklin, Stephen P Mayfield
Dec 5, 1998·Journal of Immunological Methods·T VerchH Koprowski
Aug 1, 2000·Immunology Today·M LittleG Moldenhauer
Dec 1, 1995·Trends in Biotechnology·J K Ma, M B Hein
Nov 22, 2002·Trends in Biotechnology·Ilya RaskinBertold Fridlender
Mar 21, 2001·Vaccine·H Koprowski, V Yusibov
Mar 21, 2001·Vaccine·K PeetersA Depicker
Jan 18, 2003·Vaccine·Rainer FischerStefan Schillberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Engineering

Antibody engineering technologies are constantly advancing to improve the clinical effectiveness of monoclonal and bispecific antibodies. Discover the latest research on Antibody Engineering here.